303 related articles for article (PubMed ID: 8097538)
21. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.
Ennis MD; Stjernlöf P; Hoffman RL; Ghazal NB; Smith MW; Svensson K; Wikström H; Haadsma-Svensson SR; Lin CH
J Med Chem; 1995 Jun; 38(12):2217-30. PubMed ID: 7783153
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure activity relationships of cis- and trans-2,3,4,4a,9,9a-hexahydro-1H-indeno[2,1-c]pyridines for 5-HT receptor subtypes.
Meyer MD; DeBernardis JF; Hancock AA
J Med Chem; 1994 Jan; 37(1):105-12. PubMed ID: 8289183
[TBL] [Abstract][Full Text] [Related]
24. 6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists.
Wikström H; Andersson B; Elebring T; Lagerkvist S; Hallnemo G; Pettersson I; Jovall PA; Svensson K; Ekman A; Carlsson A
J Med Chem; 1992 Oct; 35(22):3984-90. PubMed ID: 1433207
[TBL] [Abstract][Full Text] [Related]
25. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
27. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.
Homan EJ; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928
[TBL] [Abstract][Full Text] [Related]
28. Structural analogues of 5-OMe-BPAT: synthesis and interactions with dopamine D2, D3, and serotonin 5-HT1A receptors.
Homan EJ; Kroodsma E; Copinga S; Unelius L; Mohell N; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Jun; 7(6):1111-21. PubMed ID: 10428381
[TBL] [Abstract][Full Text] [Related]
29. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
Arvidsson LE; Hacksell U; Johansson AM; Nilsson JL; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A
J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
[TBL] [Abstract][Full Text] [Related]
30. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
[TBL] [Abstract][Full Text] [Related]
31. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
32. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
[TBL] [Abstract][Full Text] [Related]
33. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands.
Paluchowska MH; Dereń-Wesołek A; Mokrosz JL; Charakchieva-Minol S; Chojnacka-Wójcik E
Arch Pharm (Weinheim); 1996 Oct; 329(10):451-6. PubMed ID: 8933747
[TBL] [Abstract][Full Text] [Related]
35. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 1. Effects of substituents in the aromatic system on serotonin and dopamine receptor subtypes.
Stjernlöf P; Ennis MD; Hansson LO; Hoffman RL; Ghazal NB; Sundell S; Smith MW; Svensson K; Carlsson A; Wikström H
J Med Chem; 1995 Jun; 38(12):2202-16. PubMed ID: 7783152
[TBL] [Abstract][Full Text] [Related]
37. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
[TBL] [Abstract][Full Text] [Related]
38. Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties.
Wikström H; Andersson B; Svensson A; Humber LG; Asselin AA; Svensson K; Ekman A; Carlsson A; Nilsson I; Chidester C
J Med Chem; 1989 Oct; 32(10):2273-6. PubMed ID: 2571729
[TBL] [Abstract][Full Text] [Related]
39. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
[TBL] [Abstract][Full Text] [Related]
40. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
